Scott has been covering Jim Cramer and Mad Money for The Street since 2006, providing a nightly recap of the show and the Lightning Round as well as maintaining The Street's exclusive Mad Money Stock Screener.
Recent Articles By The Author
Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)
Upcoming earnings? Optimistic spin on trade? Tech rally? Jim Cramer's got the game plan for next week and he tells investors to keep their cool.
Verizon, Chipotle, Bank of Internet: 'Mad Money' Lightning Round
Jim Cramer takes a look at Verizon, Chipotle, Bank of Internet, Oracle, PayPal, Raytheon, Mallinckrodt, Roku, McDonald's.
Stealth Rally: Cramer's 'Mad Money' Recap (Thursday 5/10/18)
Take one part great earnings and one part tremendous skepticism, add in low inflation and you end up with this astonishing stealth rally. Jim Cramer explains it.
Online Marketplace Etsy: Cramer's Top Takeaways
Josh Silverman, CEO of the online marketplace Etsy, tells Jim Cramer about his company's technology innovations.
Zebra Technologies: Cramer's Top Takeaways
Anders Gustafsson, CEO of Zebra Technologies, tells Jim Cramer that healthcare has become the company's fastest growing vertical.
Constellation Brands, Zendesk, Box: 'Mad Money' Lightning Round
Jim Cramer weighs in on Constellation Brands, Zendesk, Box, Opko Health, Thor Industries, Hain Celestial Group and more.
Optimism and Banks Take the Lead: Cramer's 'Mad Money' Recap (Wednesday 5/9/18)
Jim Cramer says oil soared, interest rates rose, and still the market cheered. What the heck is going on?
T-Mobile US, Skechers USA, KeyCorp: 'Mad Money' Lightning Round
Jim Cramer talks about T-Mobile US, Skechers USA, KeyCorp, Philip Morris International, Mazor Robotics, and more.
Emotions Are Running This Market: Cramer's 'Mad Money' Recap (Tuesday 5/8/18)
Jim Cramer says the reason this market is so hard to deal with is that it doesn't know how to calculate an event -- even when everyone saw it coming.
CVS Health, Prestige Brands, LendingTree: 'Mad Money' Lightning Round
Jim Cramer takes a look at CVS Health, Prestige Brands, LendingTree, Valeant Pharmaceuticals, Nektar Therapeutics, Kirkland Lake and more.